AAPL   323.74 (+0.12%)
MSFT   184.32 (-0.32%)
FB   230.35 (-1.02%)
GOOGL   1,437.28 (-0.35%)
AMZN   2,470.38 (-0.08%)
NVDA   350.36 (-0.75%)
CGC   16.97 (+5.14%)
MU   48.79 (+4.19%)
GE   7.24 (+2.70%)
TSLA   884.69 (+0.36%)
AMD   52.68 (-1.61%)
T   31.54 (+1.78%)
GILD   74.26 (+1.37%)
DIS   121.98 (+2.72%)
NFLX   419.70 (-1.78%)
BAC   26.06 (+4.91%)
AAPL   323.74 (+0.12%)
MSFT   184.32 (-0.32%)
FB   230.35 (-1.02%)
GOOGL   1,437.28 (-0.35%)
AMZN   2,470.38 (-0.08%)
NVDA   350.36 (-0.75%)
CGC   16.97 (+5.14%)
MU   48.79 (+4.19%)
GE   7.24 (+2.70%)
TSLA   884.69 (+0.36%)
AMD   52.68 (-1.61%)
T   31.54 (+1.78%)
GILD   74.26 (+1.37%)
DIS   121.98 (+2.72%)
NFLX   419.70 (-1.78%)
BAC   26.06 (+4.91%)
AAPL   323.74 (+0.12%)
MSFT   184.32 (-0.32%)
FB   230.35 (-1.02%)
GOOGL   1,437.28 (-0.35%)
AMZN   2,470.38 (-0.08%)
NVDA   350.36 (-0.75%)
CGC   16.97 (+5.14%)
MU   48.79 (+4.19%)
GE   7.24 (+2.70%)
TSLA   884.69 (+0.36%)
AMD   52.68 (-1.61%)
T   31.54 (+1.78%)
GILD   74.26 (+1.37%)
DIS   121.98 (+2.72%)
NFLX   419.70 (-1.78%)
BAC   26.06 (+4.91%)
AAPL   323.74 (+0.12%)
MSFT   184.32 (-0.32%)
FB   230.35 (-1.02%)
GOOGL   1,437.28 (-0.35%)
AMZN   2,470.38 (-0.08%)
NVDA   350.36 (-0.75%)
CGC   16.97 (+5.14%)
MU   48.79 (+4.19%)
GE   7.24 (+2.70%)
TSLA   884.69 (+0.36%)
AMD   52.68 (-1.61%)
T   31.54 (+1.78%)
GILD   74.26 (+1.37%)
DIS   121.98 (+2.72%)
NFLX   419.70 (-1.78%)
BAC   26.06 (+4.91%)
Log in

NASDAQ:DMPIDelMar Pharmaceuticals SEC Filings & 10K Form

$0.81
+0.00 (+0.01 %)
(As of 06/3/2020 01:14 PM ET)
Add
Compare
Today's Range
$0.80
Now: $0.81
$0.86
50-Day Range
$0.51
MA: $0.67
$1.03
52-Week Range
$0.38
Now: $0.81
$2.66
Volume5,020 shs
Average Volume711,125 shs
Market Capitalization$9.26 million
P/E RatioN/A
Dividend YieldN/A
Beta1.73

SEC Filings

DelMar Pharmaceuticals (NASDAQ:DMPI) SEC Filings

DateFilerForm TypeView
06/02/2020
3:12 PM
DelMar Pharmaceuticals (Filer)
Form DEF 14A
05/13/2020
7:51 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
7:49 AM
DelMar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/31/2020
3:18 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
3:16 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
3:15 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2020
3:15 PM
Brown Dennis M (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
7:00 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
7:05 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
7:03 AM
DelMar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/11/2020
5:19 AM
DelMar Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
02/10/2020
2:16 PM
CVI Investments, Inc. (Filed by)
DelMar Pharmaceuticals (Subject)
Form SC 13G/A
01/23/2020
2:10 PM
DelMar Pharmaceuticals (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G/A
01/21/2020
11:17 AM
DelMar Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/07/2020
7:00 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2020
3:20 PM
Brown Dennis M (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:17 PM
DelMar Pharmaceuticals (Issuer)
Praill Anthony Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:15 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:12 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
3:10 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:02 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2019
5:05 AM
DelMar Pharmaceuticals (Filer)
Form 424B4
11/21/2019
5:03 AM
DelMar Pharmaceuticals (Filer)
Form 424B4
11/20/2019
11:15 PM
DelMar Pharmaceuticals (Filer)
Form EFFECT
11/20/2019
11:15 PM
DelMar Pharmaceuticals (Filer)
Form EFFECT
11/15/2019
3:39 PM
DelMar Pharmaceuticals (Filer)
Form POS AM
11/15/2019
3:37 PM
DelMar Pharmaceuticals (Filer)
Form POS AM
10/01/2019
3:32 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
3:22 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
3:20 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
3:14 PM
DelMar Pharmaceuticals (Issuer)
Praill Anthony Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2019
3:09 PM
Brown Dennis M (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
4:08 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
4:45 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4/A
09/16/2019
3:22 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
7:07 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
3:52 PM
DelMar Pharmaceuticals (Issuer)
Ferrara Napoleone (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:49 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:46 PM
DelMar Pharmaceuticals (Issuer)
HOFFMAN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:42 PM
Brown Dennis M (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:39 PM
DelMar Pharmaceuticals (Issuer)
Zarrabian Saiid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:36 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:34 PM
DelMar Pharmaceuticals (Issuer)
Praill Anthony Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:31 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:23 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
3:18 PM
DelMar Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/09/2019
7:58 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
7:02 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:11 PM
DelMar Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G
08/23/2019
8:59 AM
CVI Investments, Inc. (Filed by)
DelMar Pharmaceuticals (Subject)
Form SC 13G
08/16/2019
3:05 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
3:05 PM
DelMar Pharmaceuticals (Filer)
Form 8-K/A
08/15/2019
7:49 AM
DelMar Pharmaceuticals (Filer)
Form 424B4
08/15/2019
7:45 AM
DelMar Pharmaceuticals (Filer)
Form POS EX
08/14/2019
11:15 PM
DelMar Pharmaceuticals (Filer)
Form EFFECT
08/14/2019
8:12 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
4:27 PM
DelMar Pharmaceuticals (Filer)
Form S-1/A
08/01/2019
5:08 AM
DelMar Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/31/2019
8:51 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
11:15 PM
DelMar Pharmaceuticals (Filer)
Form EFFECT
07/11/2019
3:17 PM
DelMar Pharmaceuticals (Filer)
Form S-1/A
07/01/2019
3:23 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:21 PM
DelMar Pharmaceuticals (Issuer)
Praill Anthony Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:18 PM
Brown Dennis M (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
3:17 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
3:18 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
3:12 PM
DelMar Pharmaceuticals (Filer)
Form RW
06/25/2019
3:21 PM
DelMar Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/17/2019
7:00 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
3:08 PM
Anson Funds Management LP (Filed by)
DelMar Pharmaceuticals (Subject)
Form SC 13G
06/12/2019
4:24 PM
DelMar Pharmaceuticals (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G
06/10/2019
4:32 PM
DelMar Pharmaceuticals (Filer)
Form POS AM
06/05/2019
1:19 PM
DelMar Pharmaceuticals (Subject)
Empery Asset Management, LP (Filed by)
Form SC 13G
06/03/2019
4:11 PM
DelMar Pharmaceuticals (Filer)
Form 8-K/A
06/03/2019
7:31 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
5:31 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:05 PM
DelMar Pharmaceuticals (Filer)
Form 424B3
05/31/2019
1:07 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:02 PM
DelMar Pharmaceuticals (Filer)
Form 424B4
05/29/2019
7:31 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
7:18 AM
DelMar Pharmaceuticals (Filer)
Form 424B4
05/28/2019
11:15 PM
DelMar Pharmaceuticals (Filer)
Form EFFECT
05/23/2019
4:33 PM
DelMar Pharmaceuticals (Filer)
Form S-1/A
05/15/2019
4:05 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
3:01 PM
DelMar Pharmaceuticals (Filer)
Form DEF 14A
05/08/2019
6:30 AM
DelMar Pharmaceuticals (Filer)
Form S-1/A
05/08/2019
5:43 AM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
5:34 PM
DelMar Pharmaceuticals (Issuer)
Zarrabian Saiid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
5:33 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
5:32 PM
DelMar Pharmaceuticals (Issuer)
HOFFMAN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
5:31 PM
DelMar Pharmaceuticals (Issuer)
Ferrara Napoleone (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
5:29 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
5:29 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
3:59 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
5:48 AM
DelMar Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/17/2019
3:05 PM
DelMar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2019
3:40 PM
DelMar Pharmaceuticals (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:38 PM
DelMar Pharmaceuticals (Issuer)
Praill Anthony Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:37 PM
Cranston Lynda Sarah (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:27 PM
Bell John K (Reporting)
DelMar Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.